Schedule 13G Amendment No. 4

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

 

 

Simcere Pharmaceutical Group

(Name of Issuer)

 

 

Ordinary Shares, par value US$0.01 per share

(Title of Class of Securities)

82859P 10 4 1

(CUSIP Number)

December 31, 2011

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

1 

This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares.

 

 

 

 

1 of 5

CUSIP No. 82859P 10 4   13G   

 

  1   

NAME OF REPORTING PERSON

 

New Good Management Limited

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

     British Virgin Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    37,550,602 Ordinary Shares

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    37,550,602 Ordinary Shares

  9

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    37,550,602 Ordinary Shares

10

  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*    ¨

 

11

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

    34.8%

12

  

TYPE OF REPORTING PERSON*

 

    CO

 

 

2 of 5

CUSIP No. 82859P 10 4   13G   
Item 1  

(a).

    Name of Issuer:      
     Simcere Pharmaceutical Group (the “Issuer”)      
Item 1  

(b).

    Address of Issuer’s Principal Executive Offices:      
    

No.699-18 Xuan Wu Avenue

Xuan Wu District, Nanjing

Jiangsu Province 210042

The People’s Republic of China

      
Item 2  

(a).

    Name of Person Filing:      
     New Good Management Limited      
Item 2  

(b).

    Address of Principal Business Office, or, if None, Residence:      
    

No.699-18 Xuan Wu Avenue

Xuan Wu District, Nanjing

Jiangsu Province 210042

The People’s Republic of China

      
Item 2  

(c).

    Citizenship or Place of Organization:      
     British Virgin Islands      
Item 2  

(d).

    Title of Class of Securities:      
     Ordinary Shares      
Item 2  

(e).

    CUSIP Number:      
     82859P 10 4      
Item 3.   If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:   
  Not applicable   

 

3 of 5

 

Item 4.

    Ownership.      
   The following information with respect to the ownership of the Ordinary Shares of the Issuer by the person filing this statement is provided as of December 31, 2011. The percentage amount is based on 107,808,420 Ordinary Shares outstanding as of December 31, 2011, as derived from the Issuer’s corporate records.      
                  Number of shares as to which the person has:  
Reporting Person   

Amount

beneficially

owned:

     

Percent

of class:

    

Sole

power to

vote or

to direct

the vote:

     

Shared

power to

vote or to

direct

the vote:

     

Sole power

to dispose

or to

direct the

disposition

of:

     

Shared

power to

dispose or

to direct the

disposition

of:

  

New Good Management Limited

      37,550,602         34.8 %      —           37,550,602         —           37,550,602   
   New Good Management Limited (“NGM”) is the record holder of 37,550,602 Ordinary Shares of the Issuer. Prior to May 2008, NGM did not have any controlling shareholder. In May 2008, Mr. Jinsheng Ren, the Chairman of the Board of Directors of NGM (“Mr. Ren”), became a controlling shareholder of NGM. Pursuant to Rule 13d-3 under the Act, Mr. Ren may be deemed to share with NGM the voting and dispositive power over the 37,550,602 Ordinary Shares held by NGM.      
Item 5.    Ownership of Five Percent or Less of a Class.   
   Not applicable   
Item 6.    Ownership of More Than Five Percent on Behalf of Another Person.      
   Not applicable      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
   Not applicable
Item 8.    Identification and Classification of Members of the Group.      
   Not applicable      
Item 9.    Notice of Dissolution of Group.      
   Not applicable      
Item 10.    Certifications.      
   Not applicable      

 

4 of 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2012

 

New Good Management Limited
By:  

/s/ Jinsheng Ren

  Name: Jinsheng Ren
  Title: Chairman

 

5 of 5